Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Cornelissen

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Translational Lung Cancer Research|November 20, 2018
A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)Jo Raskin, Veerle Surmont, Robin Cornelissen, et al.
International Journal of Cancer|September 15, 2022
Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesotheliomaMandy van Gulijk, Bob Belderbos, Daphne Dumoulin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2019
Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapyAman Sharma, Sarah Baker, Marloes Duijm, et al.
European Journal of Cancer Care|August 2, 2021
The psychosocial impact of living with mesothelioma: Experiences and needs of patients and their carers regarding supportive careAgata Prusak, Jan Maarten van der Zwan, Mieke J Aarts, et al.
Radiation Oncology (London, England)|January 5, 2007
Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinomaRobin Cornelissen, Suresh Senan, Imogeen E Antonisse, et al.
Radiation Oncology (London, England)|April 24, 2020
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancerSarah Baker, Katerina Bakunina, Marloes Duijm, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Renal Toxicity From Pemetrexed and Pembrolizumab in the Era of Combination Therapy in Patients With Metastatic Nonsquamous Cell NSCLCDaphne W Dumoulin, Sabine Visser, Robin Cornelissen, et al.
Analytical and Bioanalytical Chemistry|September 25, 2010
A new ultrafast and high-throughput mass spectrometric approach for the therapeutic drug monitoring of the multi-targeted anti-folate pemetrexed in plasma from lung cancer patientsRoland J W Meesters, Robin Cornelissen, Rob J van Klaveren, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2016
Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patientsLysanne A Lievense, Koen Bezemer, Robin Cornelissen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2016
Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell SuppressionLysanne A Lievense, Robin Cornelissen, Koen Bezemer, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Translational Lung Cancer Research|November 20, 2018
A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)Jo Raskin, Veerle Surmont, Robin Cornelissen, et al.
International Journal of Cancer|September 15, 2022
Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesotheliomaMandy van Gulijk, Bob Belderbos, Daphne Dumoulin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2019
Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapyAman Sharma, Sarah Baker, Marloes Duijm, et al.
European Journal of Cancer Care|August 2, 2021
The psychosocial impact of living with mesothelioma: Experiences and needs of patients and their carers regarding supportive careAgata Prusak, Jan Maarten van der Zwan, Mieke J Aarts, et al.
Radiation Oncology (London, England)|January 5, 2007
Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinomaRobin Cornelissen, Suresh Senan, Imogeen E Antonisse, et al.
Radiation Oncology (London, England)|April 24, 2020
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancerSarah Baker, Katerina Bakunina, Marloes Duijm, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Renal Toxicity From Pemetrexed and Pembrolizumab in the Era of Combination Therapy in Patients With Metastatic Nonsquamous Cell NSCLCDaphne W Dumoulin, Sabine Visser, Robin Cornelissen, et al.
Analytical and Bioanalytical Chemistry|September 25, 2010
A new ultrafast and high-throughput mass spectrometric approach for the therapeutic drug monitoring of the multi-targeted anti-folate pemetrexed in plasma from lung cancer patientsRoland J W Meesters, Robin Cornelissen, Rob J van Klaveren, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2016
Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patientsLysanne A Lievense, Koen Bezemer, Robin Cornelissen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2016
Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell SuppressionLysanne A Lievense, Robin Cornelissen, Koen Bezemer, et al.
Pageof 6